Set of control materials for quality control of quantitative determination of glycated hemoglobin A1c content in whole blood by immunoturbidimetric method "GLYCOHEMOGLOBIN CONTROL ABRIS+" according to TU 21.20.23-115-27428909-2024 In versions: I. Complete set No 1 (final volume 0.5 ml), consisting of: 1. Control 1 - 1 fl. 2. Control 2 - 1 fl. 3. Instructions for use. 4. Passport. II. Complete set No 2 (final volume 1.0 ml), consisting of: 1. Control 1 - 1 fl. 2. Control 2 - 1 fl. 3. Instructions for use. 4. Passport. - Roszdravnadzor Registration РЗН 2024/23708

Access comprehensive regulatory information for Set of control materials for quality control of quantitative determination of glycated hemoglobin A1c content in whole blood by immunoturbidimetric method "GLYCOHEMOGLOBIN CONTROL ABRIS+" according to TU 21.20.23-115-27428909-2024 In versions: I. Complete set No 1 (final volume 0.5 ml), consisting of: 1. Control 1 - 1 fl. 2. Control 2 - 1 fl. 3. Instructions for use. 4. Passport. II. Complete set No 2 (final volume 1.0 ml), consisting of: 1. Control 1 - 1 fl. 2. Control 2 - 1 fl. 3. Instructions for use. 4. Passport. in the Russia medical device market through Pure Global AI's free database. This Class 2a medical device is registered under Roszdravnadzor registration number РЗН 2024/23708 and manufactured by NPF ABRIS+ LLC. The device was registered on September 25, 2024.

This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.